Advertisement

Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study)

      The Marfan syndrome (MFS) is strongly associated with aortic disease causing a high prevalence of prophylactic aortic surgery, aortic dissection, and sudden death. The aim of the present study was to evaluate mortality in a nationwide Danish MFS population diagnosed by the Ghent II criteria. In a register-based setting, we identified all Danish patients with MFS (n = 412, men n = 215) by assessment of their medical records. We established a gender and age matched control cohort based on 41,000 control patients (men n = 21,500). MFS cases risk time was 6,669 patient years. We applied Cox regression using each case and his/her control as one stratum, adjusting for age and calendar time. We found a significantly decreased lifespan of 50 years compared with 60 years among controls. The mortality hazard ratio among MFS compared with controls was significantly increased to 3.6 (CI 2.8–4.7, p < 0.001); men 4.0 (CI 2.8–5.7, p < 0.001); women 3.2 (CI 2.1–4.8, p < 0.001). Aorta disease represented the main reason for the overall increased mortality with a hazard ratio of 194.6 (CI 67.4–561.7, p < 0.0001); men 208.7 (CI 53.8–809.1, p < 0.001); women 173.4 (CI 31.5–954.5, p < 0.001). In addition, an unexplained mortality due to respiratory illness was not attributed to pneumothorax. Excluding cardiovascular and respiratory causes of death, we found no indication that MFS is associated with increased mortality for other reasons.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Groth KA
        • Hove H
        • Kyhl K
        • Folkestad L
        • Gaustadnes M
        • Vejlstrup N
        • Stochholm K
        • Ostergaard JR
        • Andersen NH
        • Gravholt CH
        Prevalence, incidence, and age at diagnosis in Marfan Syndrome.
        Orphanet J Rare Dis. 2015; 10: 153
        • Groth KA
        • Stochholm K
        • Hove H
        • Kyhl K
        • Gregersen PA
        • Vejlstrup N
        • Ostergaard JR
        • Gravholt CH
        • Andersen NH
        Aortic events in a nationwide Marfan syndrome cohort.
        Clin Res Cardiol. 2017; 106: 105-112
        • Silverman DI
        • Burton KJ
        • Gray J
        • Bosner MS
        • Kouchoukos NT
        • Roman MJ
        • Boxer M
        • Devereux RB
        • Tsipouras P
        Life expectancy in the Marfan syndrome.
        Am J Cardiol. 1995; 75: 157-160
        • Jondeau G
        • Detaint D
        • Tubach F
        • Arnoult F
        • Milleron O
        • Raoux F
        • Delorme G
        • Mimoun L
        • Krapf L
        • Hamroun D
        • Beroud C
        • Roy C
        • Vahanian A
        • Boileau C
        Aortic event rate in the Marfan population: a cohort study.
        Circulation. 2012; 125: 226-232
        • Schmidt M
        • Schmidt SA
        • Sandegaard JL
        • Ehrenstein V
        • Pedersen L
        • Sorensen HT
        The Danish National Patient Registry: a review of content, data quality, and research potential.
        Clin Epidemiol. 2015; 7: 449-490
        • Helweg-Larsen K
        The Danish Register of Causes of Death.
        Scand J Public Health. 2011; 39: 26-29
        • Roman MJ
        • Devereux RB
        • Preiss LR
        • Asch FM
        • Eagle KA
        • Holmes KW
        • LeMaire SA
        • Maslen CL
        • Milewicz DM
        • Morris SA
        • Prakash SK
        • Pyeritz RE
        • Ravekes WJ
        • Shohet RV
        • Song HK
        • Weinsaft JW
        • Gen TACI
        Associations of age and sex with Marfan phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry.
        Circ Cardiovasc Genet. 2017; 10: 1-8
        • Selamet Tierney ES
        • Levine JC
        • Sleeper LA
        • Roman MJ
        • Bradley TJ
        • Colan SD
        • Chen S
        • Campbell MJ
        • Cohen MS
        • De Backer J
        • Heydarian H
        • Hoskoppal A
        • Lai WW
        • Liou A
        • Marcus E
        • Nutting A
        • Olson AK
        • Parra DA
        • Pearson GD
        • Pierpont ME
        • Printz BF
        • Pyeritz RE
        • Ravekes W
        • Sharkey AM
        • Srivastava S
        • Young L
        • Lacro RV
        • Pediatric Heart Network I
        Influence of aortic stiffness on aortic-root growth rate and outcome in patients with the Marfan syndrome.
        Am J Cardiol. 2018; 121: 1094-1101
        • Milleron O
        • Arnoult F
        • Ropers J
        • Aegerter P
        • Detaint D
        • Delorme G
        • Attias D
        • Tubach F
        • Dupuis-Girod S
        • Plauchu H
        • Barthelet M
        • Sassolas F
        • Pangaud N
        • Naudion S
        • Thomas-Chabaneix J
        • Dulac Y
        • Edouard T
        • Wolf JE
        • Faivre L
        • Odent S
        • Basquin A
        • Habib G
        • Collignon P
        • Boileau C
        • Jondeau G
        Marfan Sartan: a randomized, double-blind, placebo-controlled trial.
        Eur Heart J. 2015; 36: 2160-2166
        • Lacro RV
        • Dietz HC
        • Sleeper LA
        • Yetman AT
        • Bradley TJ
        • Colan SD
        • Pearson GD
        • Selamet Tierney ES
        • Levine JC
        • Atz AM
        • Benson DW
        • Braverman AC
        • Chen S
        • De BJ
        • Gelb BD
        • Grossfeld PD
        • Klein GL
        • Lai WW
        • Liou A
        • Loeys BL
        • Markham LW
        • Olson AK
        • Paridon SM
        • Pemberton VL
        • Pierpont ME
        • Pyeritz RE
        • Radojewski E
        • Roman MJ
        • Sharkey AM
        • Stylianou MP
        • Wechsler SB
        • Young LT
        • Mahony L
        Atenolol versus losartan in children and young adults with Marfan's syndrome.
        N Engl J Med. 2014; 371: 2061-2071
        • De Backer J.
        Marfan and Sartans: time to wake up!.
        Eur Heart J. 2015; 36: 2131-2133
        • Franken R
        • den Hartog AW
        • Radonic T
        • Micha D
        • Maugeri A
        • van Dijk FS
        • Meijers-Heijboer HE
        • Timmermans J
        • Scholte AJ
        • van den Berg MP
        • Groenink M
        • Mulder BJ
        • Zwinderman AH
        • de Waard V
        • Pals G
        Beneficial outcome of Losartan therapy depends on type of FBN1 mutation in Marfan syndrome.
        Circ Cardiovasc Genet. 2015; 8: 383-388
        • Regitz-Zagrosek V
        • Blomstrom LC
        • Borghi C
        • Cifkova R
        • Ferreira R
        • Foidart JM
        • Gibbs JS
        • Gohlke-Baerwolf C
        • Gorenek B
        • Iung B
        • Kirby M
        • Maas AH
        • Morais J
        • Nihoyannopoulos P
        • Pieper PG
        • Presbitero P
        • Roos-Hesselink JW
        • Schaufelberger M
        • Seeland U
        • Torracca L
        ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC).
        Eur Heart J. 2011; 32: 3147-3197
        • Kuperstein R
        • Cahan T
        • Yoeli-Ullman R
        • Ben Zekry S
        • Shinfeld A
        • Simchen MJ
        Risk of aortic dissection in pregnant patients with the Marfan syndrome.
        Am J Cardiol. 2017; 119: 132-137
        • Collins JD
        • Semaan E
        • Barker A
        • McCarthy PM
        • Carr JC
        • Markl M
        • Malaisrie SC
        Comparison of hemodynamics after aortic root replacement using valve-sparing or bioprosthetic valved conduit.
        Ann Thorac Surg. 2015; 100: 1556-1562
        • den Hartog AW
        • Franken R
        • Zwinderman AH
        • Timmermans J
        • Scholte AJ
        • van den Berg MP
        • de WV
        • Pals G
        • Mulder BJ
        • Groenink M
        The risk for type B aortic dissection in Marfan syndrome.
        J Am Coll Cardiol. 2015; 65: 246-254
        • Mimoun L
        • Detaint D
        • Hamroun D
        • Arnoult F
        • Delorme G
        • Gautier M
        • Milleron O
        • Meuleman C
        • Raoux F
        • Boileau C
        • Vahanian A
        • Jondeau G
        Dissection in Marfan syndrome: the importance of the descending aorta.
        Eur Heart J. 2011; 32: 443-449
        • Ghanta RK
        • Green SY
        • Price MD
        • Arredondo CC
        • Wainwright D
        • Preventza O
        • de la Cruz KI
        • Aftab M
        • LeMaire SA
        • Coselli JS
        Midterm survival and quality of life after extent II thoracoabdominal aortic repair in Marfan syndrome.
        Ann Thorac Surg. 2016; 101 (discussion 1409): 1402-1409
        • Lima B
        • Nowicki ER
        • Blackstone EH
        • Williams SJ
        • Roselli EE
        • Sabik JF
        • 3rd, Lytle BW
        • Svensson LG
        Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: the role of intrathecal papaverine.
        J Thorac Cardiovasc Surg. 2012; 143e941
        • Beighton P
        • de PA
        • Danks D
        • Finidori G
        • Gedde-Dahl T
        • Goodman R
        • Hall JG
        • Hollister DW
        • Horton W
        • McKusick VA
        International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986.
        Am J Med Genet. 1988; 29: 581-594
        • De Paepe A
        • Devereux RB
        • Dietz HC
        • Hennekam RC
        • Pyeritz RE
        Revised diagnostic criteria for the Marfan syndrome.
        Am J Med Genet. 1996; 62: 417-426
        • Loeys BL
        • Dietz HC
        • Braverman AC
        • Callewaert BL
        • De BJ
        • Devereux RB
        • Hilhorst-Hofstee Y
        • Jondeau G
        • Faivre L
        • Milewicz DM
        • Pyeritz RE
        • Sponseller PD
        • Wordsworth P
        • De Paepe AM
        The revised Ghent nosology for the Marfan syndrome.
        J Med Genet. 2010; 47: 476-485